We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Screening for Glaucoma--Through the Eyelid

By HospiMedica staff writers
Posted on 09 Jan 2008
An innovative device has turned screening for glaucoma into a safe, easy procedure, performed through the eyelid and without the use of anesthetic drops.

The Diaton is a small, pen-like, hand-held, portable tonometer that scans intraocular pressure (IOP) transpalpebrally (without touching the cornea). More...
The tip of the tonometer rests on the eyeball through the upper eyelid during IOP measurement, and can freely move along the tonometer's axis relatively its body. This provides a constant static load on the eye during IOP measurement, with the eyelid acting as the transmissive part during the interaction. The tip is provided with supports in the form of two protrusions, which helps to eliminate damping properties of the eyelid as well as to fix the position of the tonometer in relation to the eyeball during measuring.

A built-in signaling indicator helps to control the vertical position of the tonometer directly before or during measuring; keeping the device in vertical position during tonometry provides optimal characteristics of the rod movement that increases measuring accuracy. An interrupted sound signal before measuring indicates the device's deviation from the vertical line for more than 4.5°, and the frequency of the sound signals increases as the tonometer is moved closer to a vertical line. Lack of the sound signal indicates that it is possible to carry out the measurement, as the device is in a vertical position. The tonometry result appears on the display and is preserved for 30 seconds. The Diaton tonometer is a product of BiCOM (Long Beach, NY, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"With the introduction of our unique tonometer Diaton, we're proud to challenge Glaucoma, a ‘silent thief of sight,' that carries an ever increasing threat of causing blindness as the aging population is growing in the U.S. and abroad,” said Roman Iospa, CEO of BiCOM.

Tonometry measures IOP by recording the resistance of the cornea to pressure by indentation. The transpalpebral approach was developed for patients with corneal concerns such as conjunctivitis, edema, erosion, cornea pathology, a high degree of ametropy or astigmatism, or for acquiring IOPs following laser refractive and other corneal surgeries.


Related Links:
BiCOM

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.